The unified social credit code/registration number of Shanghai Baimaibo Pharmaceutical Co., Ltd. is 9131000695796219w, and the enterprise is in the opening state.
The business scope of Shanghai Baimaibo Pharmaceutical Co., Ltd. is: research and development of medicine and biotechnology products (except human stem cells and gene diagnosis and treatment), transfer of its own technological achievements; Production and sales of bioengineering products (recombinant human-mouse chimeric monoclonal antibody against tumor necrosis factor A for injection). Projects that are subject to approval according to law can only carry out business activities after being approved by relevant departments. In Shanghai, the total registered capital of companies with similar business scope is 835 1.3 million yuan, and the main capital is concentrated in 33 enterprises with the scale of/kloc-0.5 million-50 million and 50 million. Within the scope of this province, the registered capital of mobile enterprises belongs to the general.
Shanghai Baimaibo Pharmaceutical Co., Ltd. invested 1 company and 0 branches.
See more information and materials of Shanghai Baimaibo Pharmaceutical Co., Ltd. through Baidu Enterprise Credit.